National Center for Advancing Translational Sciences (NCATS)

See the following -

3Rs For Innovating Novel Antibiotics: Sharing Resources, Risks, And Rewards

Anthony D So, Quentin Ruiz-Esparza, Neha Gupta, Otto Cars | BMJ | April 3, 2012

The stream of new antibiotics is struggling to keep up with emerging bacterial resistance. Anthony So and colleagues examine what can be done to increase innovation... Read More »

How To Lead A Team To Greatness, From The Man Who Sequenced The Human Genome

Mark Micheli | Nextgov | June 5, 2013

From sequencing the human genome to running the largest biomedical research agency in the world, Dr. Francis Collins, Director of the National Institutes of Health, has a record of harnessing complex public institutions to get things done. Read More »

Let’s Build A Drug! Biopharma Startup Launches Crowdsourcing Tool To Pick Compounds

Stephanie Baum | MedCity News | October 24, 2012

A biopharma startup believes that when it comes to deciding what conditions it should develop drugs to treat, the decision should be left to a public vote. Read More »

The Doctor Is In

Mark Mitchell | Government Executive | July 1, 2013

I’m a little underslept today,” Dr. Francis Collins laughs, sitting in his office in the historic Building 1 of the National Institutes of Health’s sprawling campus in Bethesda, Md., where he presides as the dean of the nation’s health. [...] Read More »

Transparency Life Sciences Awarded $1.4 Million NCATS SBIR Grant To Conduct Innovative Trial Of Lisinopril In Multiple Sclerosis

Press Release | Transparency Life Sciences | September 8, 2014

Transparency Life Sciences, LLC (TLS)...today announced that it has received a Small Business Innovation Research (SBIR) program grant to fund a Phase 2a proof-of-concept study testing the utility of the ACE inhibitor lisinopril as an adjunctive therapy for multiple sclerosis (MS).

Read More »